These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11267564)

  • 1. Psychodynamic evaluation of kidney transplant patients enrolled in a new immunosuppressive drug trial.
    Nesci DA; Favale C; Foco M; Castagneto M; Nanni G
    Transplant Proc; 2001; 33(1-2):1907-8. PubMed ID: 11267564
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase III trial of Rapamune versus placebo in primary renal allograft recipients.
    Ponticelli C; MacDonald AS; Rajagopalan P; Sindhi R; Mathew T
    Transplant Proc; 2001 May; 33(3):2271-2. PubMed ID: 11377525
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors that influence nonadherence in immunosuppressant treatment in pediatric transplant recipients: a proposal for an educational strategy.
    Delucchi A; Gutierrez H; Arrellano P; Slater C; Meneses M; López I
    Transplant Proc; 2008 Nov; 40(9):3241-3. PubMed ID: 19010243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplant recipients.
    Waterman A
    Nephrol News Issues; 2006 Sep; 20(10):S7. PubMed ID: 16977930
    [No Abstract]   [Full Text] [Related]  

  • 5. Placebo-controlled study of a humanized anti-TAC monoclonal antibody in dual therapy for prevention of acute rejection after renal transplantation.
    Charpentier B; Thervet E
    Transplant Proc; 1998 Jun; 30(4):1331-2. PubMed ID: 9636541
    [No Abstract]   [Full Text] [Related]  

  • 6. Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors.
    Mulloy LL; Wright F; Hall ML; Moore M
    Transplant Proc; 1999; 31(1-2):1210-3. PubMed ID: 10083541
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic evaluation of therapeutic drug monitoring services in renal transplant recipients treated with cyclosporine.
    Lee KL; Peng YL; Chou JL; Lee KT; Chung HM
    Transplant Proc; 2000 Nov; 32(7):1801-6. PubMed ID: 11119944
    [No Abstract]   [Full Text] [Related]  

  • 8. Significance of HLA matching in renal transplantation from living donors.
    Górski A
    Transplant Proc; 1996 Dec; 28(6):3578. PubMed ID: 8962386
    [No Abstract]   [Full Text] [Related]  

  • 9. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel scale of immunosuppression exposure and correlation to outcomes after renal transplantation.
    Morrissey PE; Gohh RY; Monaco AP
    Transplant Proc; 2002 Aug; 34(5):1640-1. PubMed ID: 12176517
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporine-related hemolytic-uremic syndrome in kidney graft recipients: clinical and histomorphologic evaluation.
    Bren AF; Kandus A; Buturovic J; Koselj M; Kaplan Pavlovcic S; Ponikvar R; Kovac D; Lindic J; Vizjak A; Ferluga D
    Transplant Proc; 1998 Jun; 30(4):1201-3. PubMed ID: 9636487
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for noncompliance to immunosuppressive medications in renal transplant recipients.
    Ghods AJ; Nasrollahzadeh D; Argani H
    Transplant Proc; 2003 Nov; 35(7):2609-11. PubMed ID: 14612038
    [No Abstract]   [Full Text] [Related]  

  • 13. Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation.
    Loghman-Adham M
    Am J Manag Care; 2003 Feb; 9(2):155-71. PubMed ID: 12597603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.
    Brattström C; Tydén G; Säwe J; Herlenius G; Claesson K; Groth CG
    Transplant Proc; 1996 Apr; 28(2):985-6. PubMed ID: 8623489
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of two biopsy techniques for renal transplant assessment.
    Boyvat F; Tarhan NC; Coşkun M; Ağildere AM; Tutar NU; Bilgin N
    Transplant Proc; 1998 May; 30(3):777-9. PubMed ID: 9595094
    [No Abstract]   [Full Text] [Related]  

  • 16. Results of renal transplantation over 20 years after surgery, using azathioprine and low-dose prednisolone as the sole immunosuppression.
    Yoshimura N; Okamoto M; Akioka K; Nakamura K; Ushigome H; Kadotani Y; Nobori S; Higuchi A; Ohmori Y
    Transplant Proc; 2003 Feb; 35(1):143-4. PubMed ID: 12591340
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of acute rejection in chronic rejection.
    Vanrenterghem Y
    Transplant Proc; 1998 Jun; 30(4):1210-1. PubMed ID: 9636491
    [No Abstract]   [Full Text] [Related]  

  • 18. Infection in the renal transplant recipient.
    Kim HC; Park SB
    Transplant Proc; 2000 Nov; 32(7):1974-5. PubMed ID: 11120025
    [No Abstract]   [Full Text] [Related]  

  • 19. Mofetil mycophenolate in renal transplantation.
    Pretagostini R; Rossi M; Berloco P; Colonnello M; Bruzzone P; Peritore D; Lonardo MT; Cortesini R
    Transplant Proc; 2001; 33(1-2):1082-3. PubMed ID: 11267200
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality of life after cadaveric renal transplantation from a non-heart-beating donor.
    Shimada H; Sakamoto K; Hori S; Asano T; Suzuki T; Gunji Y; Nakajima K; Kenmochi T; Hayashi H; Takeda A; Arita S; Kashiwabara H; Yokoyama T; Ochiai T
    Transplant Proc; 2000 Nov; 32(7):1606-7. PubMed ID: 11119857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.